October 28th, 2019

Cytovia Therapeutics CEO Daniel Teper sat down with Proactive at the BIO Investor Forum in San Francisco.

Teper says he believes the scientific community is 'warming up' to natural killer (NK) cell treatments in cancer. Privately-held Cytovia Therapeutics is building a portfolio of products to harness the power of NK cells to treat cancer. 


Subscribe Form

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube